Literature DB >> 25867860

Nanomaterials for enhanced immunity as an innovative paradigm in nanomedicine.

Anushree Seth1, Doo-Byoung Oh, Yong Taik Lim.   

Abstract

Since the advent of nanoparticle technology, novel and versatile properties of nanomaterials have been introduced, which has constantly expanded their applications in therapeutics. Introduction of nanomaterials for immunomodulation has opened up new avenues with tremendous potential. Interesting properties of nanoparticles, such as adjuvanticity, capability to enhance cross-presentation, polyvalent presentation, siRNA delivery for silencing of immunesuppressive gene, targeting and imaging of immune cells have been known to have immense utility in vaccination and immunotherapy. A thorough understanding of the merits associated with nanomaterials is crucial for designing of modular and versatile nanovaccines, for improved immune response. With the emerging prerequisites of vaccination, nanomaterial-based immune stimulation, seems to be capable of taking the field of immunization to a next higher level.

Keywords:  adjuvant; antigen; antigen presenting cells; cross-presentation; immune response; nanoparticle; vaccine

Mesh:

Substances:

Year:  2015        PMID: 25867860     DOI: 10.2217/nnm.14.200

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  7 in total

1.  Nanostructured lipid carriers loaded with resveratrol modulate human dendritic cells.

Authors:  João P Barbosa; Ana R Neves; Andreia M Silva; Mário A Barbosa; M Salette Reis; Susana G Santos
Journal:  Int J Nanomedicine       Date:  2016-07-28

Review 2.  Polyethylenimine-based micro/nanoparticles as vaccine adjuvants.

Authors:  Chen Shen; Jun Li; Yi Zhang; Yuce Li; Guanxin Shen; Jintao Zhu; Juan Tao
Journal:  Int J Nanomedicine       Date:  2017-07-31

3.  Combining vasculature disrupting agent and Toll-like receptor 7/8 agonist for cancer therapy.

Authors:  Anushree Seth; Hyunseung Lee; Mi Young Cho; Cheongsoo Park; Sovannarith Korm; Joo-Yong Lee; Inpyo Choi; Yong Taik Lim; Kwan Soo Hong
Journal:  Oncotarget       Date:  2017-01-17

4.  Inhibition of cancer cell migration with CuS@ mSiO2-PEG nanoparticles by repressing MMP-2/MMP-9 expression.

Authors:  Guoying Deng; Feng Zhou; Zizheng Wu; Fei Zhang; Kerun Niu; Yingjie Kang; Xijian Liu; Qiugen Wang; Yin Wang; Qian Wang
Journal:  Int J Nanomedicine       Date:  2017-12-21

5.  Synthetic vaccine particles for durable cytolytic T lymphocyte responses and anti-tumor immunotherapy.

Authors:  Petr O Ilyinskii; Grigoriy I Kovalev; Conlin P O'Neil; Christopher J Roy; Alicia M Michaud; Natalia M Drefs; Mikhail A Pechenkin; Fen-Ni Fu; Lloyd P M Johnston; Dmitry A Ovchinnikov; Takashi Kei Kishimoto
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

Review 6.  Gold nanoparticles for preparation of antibodies and vaccines against infectious diseases.

Authors:  Lev A Dykman
Journal:  Expert Rev Vaccines       Date:  2020-04-28       Impact factor: 5.217

7.  Hemagglutinin Nanoparticulate Vaccine with Controlled Photochemical Immunomodulation for Pathogenic Influenza-Specific Immunity.

Authors:  Hayoon Jeong; Chung-Sung Lee; Jangsu Lee; Jonghwan Lee; Hee Sook Hwang; Min Lee; Kun Na
Journal:  Adv Sci (Weinh)       Date:  2021-10-24       Impact factor: 16.806

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.